CoSara Diagnostics, a Joint Venture (JV) of a subsidiary of Ambalal Sarabhai Enterprises and Co-Diagnostics, Inc, Salt Lake City, Utah, USA, has obtained regulatory approval from Central Drugs Standard Control Organisation (CDSCO) to manufacture and sale SARAGENE Chikungunya Virus (CHIKV) Test Kit for diagnosis of Chikungunya Virus.
The Test Kit is an in vitro diagnostic test, based on Real-Time Polymerase Chain Reaction Technology. Test utilizes Co-Diagnostics' patented CoPrimers technology (Satterfield, 2014) (Poritz & Ririe, 2014). It tests for the presence or absence of ribonucleic acid (RNA) of chikungunya virus in serum or plasma from patients suspected of chikungunya viral infections.
Ambalal Sarabhai Enterprises is engaged in manufacturing and marketing of pharmaceutical products, bulk drugs, industrial chemicals, detergents, toiletries, electronics, engineering products, paper, glass and plastic containers and packaging materials.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1841.30 |
| Dr. Reddys Lab | 1313.45 |
| Cipla | 1373.55 |
| Zydus Lifesciences | 942.60 |
| Lupin | 2472.30 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: